DE602004016371D1 - Peptid-erhöhende fusiogene kapazität eines gameten - Google Patents

Peptid-erhöhende fusiogene kapazität eines gameten

Info

Publication number
DE602004016371D1
DE602004016371D1 DE602004016371T DE602004016371T DE602004016371D1 DE 602004016371 D1 DE602004016371 D1 DE 602004016371D1 DE 602004016371 T DE602004016371 T DE 602004016371T DE 602004016371 T DE602004016371 T DE 602004016371T DE 602004016371 D1 DE602004016371 D1 DE 602004016371D1
Authority
DE
Germany
Prior art keywords
increasing
capacity
ovocytes
fusiogenic
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004016371T
Other languages
English (en)
Inventor
Morgane Bomsel
Jean-Philippe Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Sorbonne Paris Nord Paris 13
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Sorbonne Paris Nord Paris 13
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Sorbonne Paris Nord Paris 13 filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602004016371D1 publication Critical patent/DE602004016371D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/123—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602004016371T 2003-11-19 2004-11-19 Peptid-erhöhende fusiogene kapazität eines gameten Active DE602004016371D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0313545A FR2862225B1 (fr) 2003-11-19 2003-11-19 Peptide augmentant la capacite fusiogene de l'ovocyte
PCT/FR2004/002956 WO2005051799A2 (fr) 2003-11-19 2004-11-19 Peptide augmentant la capacite fusiogene d'une gamete

Publications (1)

Publication Number Publication Date
DE602004016371D1 true DE602004016371D1 (de) 2008-10-16

Family

ID=34508583

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004016371T Active DE602004016371D1 (de) 2003-11-19 2004-11-19 Peptid-erhöhende fusiogene kapazität eines gameten

Country Status (8)

Country Link
US (2) US8883742B2 (de)
EP (1) EP1684788B1 (de)
AT (1) ATE406905T1 (de)
CA (1) CA2546498C (de)
DE (1) DE602004016371D1 (de)
ES (1) ES2313116T3 (de)
FR (1) FR2862225B1 (de)
WO (1) WO2005051799A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862225B1 (fr) 2003-11-19 2006-06-02 Univ Paris 13 Peptide augmentant la capacite fusiogene de l'ovocyte
FR3041260B1 (fr) 2015-09-21 2020-10-02 Hopitaux Paris Assist Publique Utilisation d'un tripeptide cyclique pour stimuler l'activite mitochondriale de cellules
WO2019097290A1 (en) * 2017-11-15 2019-05-23 Aratinga.Bio Enhancement of biologics production in cell culture systems by fertilin-derived peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
AU2958195A (en) * 1994-06-29 1996-01-25 Texas Biotechnology Corporation Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
FR2862225B1 (fr) 2003-11-19 2006-06-02 Univ Paris 13 Peptide augmentant la capacite fusiogene de l'ovocyte

Also Published As

Publication number Publication date
ES2313116T3 (es) 2009-03-01
EP1684788B1 (de) 2008-09-03
EP1684788A2 (de) 2006-08-02
CA2546498A1 (fr) 2005-06-09
FR2862225A1 (fr) 2005-05-20
US20070082839A1 (en) 2007-04-12
US8883742B2 (en) 2014-11-11
WO2005051799A3 (fr) 2006-04-06
US20150051152A1 (en) 2015-02-19
ATE406905T1 (de) 2008-09-15
CA2546498C (fr) 2013-04-02
WO2005051799A2 (fr) 2005-06-09
FR2862225B1 (fr) 2006-06-02
US9238807B2 (en) 2016-01-19

Similar Documents

Publication Publication Date Title
CN103384680B (zh) 细胞培养基
Reinhold et al. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor‐β1 in PWM‐stimulated PBMC and T cells
CN104364263A (zh) 含有层粘连蛋白和钙粘蛋白的细胞培养基底
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
RU2008126743A (ru) Способ получения фармацевтической композиции
CY1108689T1 (el) Ολιγοπεπτιδια για την ελαττωση αυξημενης συγκεντρωσεως της ουριας στο αιμα
ATE533785T1 (de) Peptidfragmente zur induzierung der synthese extrazellulärer matrixproteine
ES2585580T3 (es) Péptidos novedosos antienvejecimiento y composición cosmética y/o farmacéutica que los contiene
ATE462000T1 (de) Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
Ullrich et al. Biosynthesis and secretion of an osteopontin-related 20-kDa polypeptide in the Madin-Darby canine kidney cell line
Hamatani et al. A monoclonal antibody to human SP-10 inhibits in vitro the binding of human sperm to hamster oolemma but not to human Zona pellucida
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
ATE406905T1 (de) Peptid-erhöhende fusiogene kapazität eines gameten
ATE546539T1 (de) Revertierung der negativ-selektiven wirkung von negativen markerproteinen als selektionsverfahren
Fligiel et al. Laminin production by murine melanoma cells: possible involvement in cell motility
Capkova et al. Monoclonal antibody to human sperm acrosomal protein
ATE381572T1 (de) Synthese von spongosin
DE60234847D1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
FR2873698B1 (fr) Nouveau peptide et composition pharmaceutique le contenant
WO2006023211A3 (en) Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
RU2021126641A (ru) Способ улучшения ангиогенного потенциала мезенхимальной стволовой клетки
DE602004023311D1 (de) Antigen-zufuhrsystem
ATE449863T1 (de) Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese
Miotto Does leucine regulate autophagy through a plasma membrane receptor? Identification of a hepatic glycoprotein supporting this hypothesis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition